OLP CLOTRIMAZOLE

Manufacturer
OHIO LAB PHARMA
Effective date
2018-11-26
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-02 00:45:35

Label at a glance#

ProductOLP CLOTRIMAZOLE
Active ingredientCLOTRIMAZOLE
Label structure13 sections

Indications and uses

cures most athlete's foot, jock itch and ringworm relieves itching, burning, cracking, scaling and discomfort which accompany these conditions

Dosage and administration

wash the affected area and dry thoroughly apply a thin layer of the product over affected area twice daily (morning and night), or as directed by a doctor supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily for athlete's foot and ringworm, use daily for 4 weeks; for jo...

Storage and handling

store at controlled room temperature 59°-86°F (15°-30°C). before using any medication, read all label directions. Keep carton, it contains important information.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Clotrimazole 1%

PURPOSE

OTC - PURPOSE SECTION

Antifungal

USES

INDICATIONS & USAGE SECTION

  • cures most athlete's foot, jock itch and ringworm
  • relieves itching, burning, cracking, scaling and discomfort which accompany these conditions

WARNINGS SECTION

For external use only

Do not use:

OTC - DO NOT USE SECTION

  • Do not use on children under 2 years of age unless directed by a doctor.

WHEN USING THIS PRODUCT

OTC - WHEN USING SECTION

avoid contact with the eyes

Stop use and ask your doctor if:

OTC - STOP USE SECTION

  • rritation occurs
  • there is no improvement within 4 weeks (for athlete's foot and ringworm) or within 2 weeks (for jock itch)

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • wash the affected area and dry thoroughly
  • apply a thin layer of the product over affected area twice daily (morning and night), or as directed by a

doctor

  • supervise children in the use of this product
  • for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes,

and change shoes and socks at least once daily

  • for athlete's foot and ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks
  • if condition lasts longer, contact a doctor
  • this product is not effective on the scalp or nails

Other information

STORAGE AND HANDLING SECTION

  • store at controlled room temperature 59°-86°F (15°-30°C).
  • before using any medication, read all label directions. Keep carton, it contains important information.

Inactive ingredients

INACTIVE INGREDIENT SECTION

sodium cetostearyl sulfate, cetostearyl alcohol, stearic acid, trolamine, octyldodecanol, ceteareth-12, propylene glycol, methyl parabeen, propyl paraben, EDTA disodium, vitamin E, water

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

clotrimazoleclotrimazole

OLP CLOTRIMAZOLE 1%

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70648-500-012020-08-25C16284748780-19d75b9cf-cdcd-f424-e053-dadaa90a57ce3b72d624-57fb-2ca5-e054-00144ff88e88
70648-500-012020-01-31C16284748780-19d75b9cf-cdcd-f424-e053-dadaa90a57ce3b72d624-57fb-2ca5-e054-00144ff88e88

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70648-50070648-500-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ada493cd-68fe-2605-e053-2a95a90ab9113b72d624-57fb-2ca5-e054-00144ff88e882020-08-24WarningsExact identifier
spl set id: 3b72d624-57fb-2ca5-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.